Listening to the community's needs, the Sickle Cell Consortium also created the Caregiver Summit, offering a vital space for ...

This week's Guest Voice is Richard Bayliss, who talks about three coping tools he's found useful in living with sickle cell ...

Despite reports of a sickle cell patient being cured by gene therapy, columnist Oluwatosin Adesoye explains why she remains ...

Leaders and advocates gather for the 9th Annual Leadership Summit of the Sickle Cell Community Consortium, celebrating ...

A sickle cell patient, Bello Kehinde, opens up to TEMITOPE ADETUNJI about her inspiring journey living with the disease, the strength and resilience that carried her through the most challenging ...

Martin Mwita, 20, is the first patient in St. Louis and among the first across the country to receive a new gene therapy for ...

Bishop T.D. Jakes announced his plans Sunday morning to appoint Pastors Touré Roberts and Sarah Jakes Roberts as senior ...

Vertex Pharma's £1.65 million ($2.05 million) gene-editing therapy for sickle cell disease (SCD), Casgevy, has been given the green light for use by the NHS in England under a managed access ...

Sickle cell disease (SCD) affects an estimated 20 million people worldwide. As a genetic condition that leads to severe, lifelong complications, SCD remains a significant unmet medical need with ...

A new technology in the form of a bracelet that helps children better understand how others play and interact has been developed by University of Bristol researchers. The research is published in ...